Last week, the Dalal Street witnessed three mainboard segment IPOs raising over ₹6,000 crore amid ongoing general elections in the country. Also read: Indegene IPO: What does GMP signal ahead of share listing on Monday? “What’s noteworthy is the robust domestic inflow, particularly with retail investors showing keen interest in […]
Indegene IPO
Indegene IPO allotment has been finalised and the investors now look up to the Indegene IPO listing which is scheduled on Monday. Ahead of the share listing, Indegene IPO GMP today indicates a strong stock market debut. The initial public offering (IPO) of Indegene Ltd, the provider of digital services […]
The company provides digitally-driven commercialization services to the life sciences sector, encompassing drug development, clinical trials, regulatory filings, pharmacovigilance, complaints management, and product sales and marketing. This sector includes biopharmaceutical, emerging biotech, and medical device companies. Also read: Indegene IPO day 3: GMP, subscription status, review, other details. Apply or […]
With an impressive response across categories, the Indegene IPO has been fully booked on its first day itself. The category for non-institutional investors fetched 4.13 times subscription, while the portion for retail investors got subscribed 1.50 times. The quota for employees received 1.31 times subscription. Indegene IPO subscription status is […]
The primary market will witness opening of three new IPOs in the mainboard segment and six new IPOs in the small and medium enterprise (SME) segment. Also read: SK Finance files DRHP with SEBI to raise ₹2,200-crore via IPO; details here “Since 2004, there hasn’t been a single IPO launch […]
Indegene IPO: The Initial Public offering (IPO) of Indegene Limited is a rare event, set to hit the Indian primary market on 6th May 2024. This marks a significant departure from the norm, as there has not been a single IPO launch during May in the last four General Election […]
Indegene Limited, on May 3, garnered over ₹548.77 crore from anchor investors at the upper price band of ₹452 per equity share ahead of initial public offerings (IPO). Indegene IPO, which is scheduled to open for subscription on May 4, has allocated 12,141,102 equity shares to 36 anchor investors, as […]